[
  {
    "id": "e3310c1a-5fe0-4e59-95b8-6410d8fd8031",
    "licenceHolderId": "304235c0-1a83-49f0-87ca-b11b1ad1e147",
    "establishmentId": 8201,
    "title": "Basic user project",
    "issueDate": "2017-02-05",
    "expiryDate": "2019-10-01",
    "licenceNumber": "PR-250872"
  },
  {
    "id": "e1f488fb-a9d0-4e55-aca7-396d31e9f814",
    "establishmentId": 8201,
    "title": "Search for the luminescent aether",
    "issueDate": "2016-02-05",
    "expiryDate": "2018-03-01",
    "licenceNumber": "PR-764848"
  },
  {
    "id": "f638b9b2-e11b-477a-84f9-fd6755f428c3",
    "establishmentId": 8201,
    "title": "Evaluation of novel anti-cancer agents",
    "issueDate": "2016-02-05",
    "expiryDate": "2018-07-01",
    "licenceNumber": "PR-250436"
  },
  {
    "id": "a09937d7-6c05-4dea-bd5f-3ba8168875cb",
    "establishmentId": 8201,
    "title": "Development of new biological anti-cancer agents",
    "issueDate": "2017-10-01",
    "expiryDate": "2018-08-01",
    "licenceNumber": "PR-890458"
  },
  {
    "id": "7828ae88-68a8-404b-ab53-ff1077722f07",
    "establishmentId": 8201,
    "title": "Thermosensitive nanoparticles for cancer therapy",
    "issueDate": "2015-11-24",
    "expiryDate": "2018-09-01",
    "licenceNumber": "PR-192985"
  },
  {
    "id": "b8b28a7b-3157-41c8-ae3f-7baf33085e8d",
    "establishmentId": 8201,
    "title": "Oncolytic HSV as an anti-cancer therapy",
    "issueDate": "2018-02-24",
    "expiryDate": "2018-10-01",
    "licenceNumber": "PR-278783"
  },
  {
    "id": "c2334f4e-f8ce-4fb6-a726-5f87ee26da55",
    "establishmentId": 8201,
    "title": "Hypoxy and angiogenesis in cancer therapy",
    "issueDate": "2017-04-23",
    "expiryDate": "2018-11-01",
    "licenceNumber": "PR-671216"
  },
  {
    "id": "5a1ad546-f347-4f65-b905-595d64932da2",
    "establishmentId": 8201,
    "title": "Evaluation of novel anti-cancer agents",
    "issueDate": "2016-02-05",
    "expiryDate": "2018-12-01",
    "licenceNumber": "PR-050381"
  },
  {
    "id": "ce80a27b-054c-4264-a60b-469a67413d73",
    "establishmentId": 8201,
    "title": "Development of new biological anti-cancer agents",
    "issueDate": "2017-10-01",
    "expiryDate": "2019-01-01",
    "licenceNumber": "PR-787013"
  },
  {
    "id": "8b946810-e202-412d-95ba-d9473fc600d3",
    "establishmentId": 8201,
    "title": "Thermosensitive nanoparticles for cancer therapy",
    "issueDate": "2015-11-24",
    "expiryDate": "2019-02-01",
    "licenceNumber": "PR-519417"
  },
  {
    "id": "7f28e0d2-3431-4b4b-bf77-3652f1968c5d",
    "establishmentId": 8201,
    "title": "Oncolytic HSV as an anti-cancer therapy",
    "issueDate": "2018-02-24",
    "expiryDate": "2019-03-01",
    "licenceNumber": "PR-265039"
  },
  {
    "id": "4e3241d6-5725-489f-bdf9-8b688a7a85c7",
    "establishmentId": 8201,
    "title": "Hypoxy and angiogenesis in cancer therapy",
    "issueDate": "2017-04-23",
    "expiryDate": "2019-04-01",
    "licenceNumber": "PR-127482"
  },
  {
    "id": "01a55d81-76b7-42eb-957e-c31d69da52d4",
    "establishmentId": 8201,
    "title": "Evaluation of novel anti-cancer agents",
    "issueDate": "2016-02-05",
    "expiryDate": "2019-05-01",
    "licenceNumber": "PR-635078"
  },
  {
    "id": "f05b13d5-de41-4173-b313-cd165c8f8072",
    "establishmentId": 8201,
    "title": "Development of new biological anti-cancer agents",
    "issueDate": "2017-10-01",
    "expiryDate": "2019-06-01",
    "licenceNumber": "PR-141529"
  },
  {
    "id": "e15b1645-730e-40ea-a177-7fee4ab757cb",
    "establishmentId": 8201,
    "title": "Thermosensitive nanoparticles for cancer therapy",
    "issueDate": "2015-11-24",
    "expiryDate": "2019-07-01",
    "licenceNumber": "PR-377835"
  },
  {
    "id": "6d2c6e8c-d38f-48b5-806b-ac698e5d4f6e",
    "establishmentId": 8201,
    "title": "Oncolytic HSV as an anti-cancer therapy",
    "issueDate": "2018-02-24",
    "expiryDate": "2019-08-01",
    "licenceNumber": "PR-474098"
  },
  {
    "id": "09971443-dfcb-483d-88f7-d0bacbbf4d76",
    "establishmentId": 8201,
    "title": "Hypoxy and angiogenesis in cancer therapy",
    "issueDate": "2017-04-23",
    "expiryDate": "2019-09-01",
    "licenceNumber": "PR-627808"
  },
  {
    "id": "6a651f3b-fa06-460f-a321-147b4002e20a",
    "establishmentId": 8201,
    "title": "Evaluation of novel anti-cancer agents",
    "issueDate": "2016-02-05",
    "expiryDate": "2019-10-01",
    "licenceNumber": "PR-398957"
  },
  {
    "id": "3dfbaca9-8ff4-4509-b0ef-763b6a31b2ac",
    "establishmentId": 8201,
    "title": "Development of new biological anti-cancer agents",
    "issueDate": "2017-10-01",
    "expiryDate": "2019-11-01",
    "licenceNumber": "PR-404484"
  },
  {
    "id": "855d6a51-338d-4c81-ae6f-d2dc89674c66",
    "establishmentId": 8201,
    "title": "Thermosensitive nanoparticles for cancer therapy",
    "issueDate": "2015-11-24",
    "expiryDate": "2019-12-01",
    "licenceNumber": "PR-374785"
  },
  {
    "id": "2319e33e-ffa0-4197-bb92-26a38c18662e",
    "establishmentId": 8201,
    "title": "Oncolytic HSV as an anti-cancer therapy",
    "issueDate": "2018-02-24",
    "expiryDate": "2020-01-01",
    "licenceNumber": "PR-439411"
  },
  {
    "id": "d42196ff-eb93-4b20-8b71-22673901873d",
    "establishmentId": 8201,
    "title": "Hypoxy and angiogenesis in cancer therapy",
    "issueDate": "2017-04-23",
    "expiryDate": "2020-03-01",
    "licenceNumber": "PR-670832"
  }
]
